Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Histone Deacetylase Inhibition Provides Tissue-Specific Protection after Renal and Liver Ischemia Reperfusion Injury — Seth J. Concors (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Histone Deacetylase Inhibition Provides Tissue-Specific Protection after Renal and Liver Ischemia Reperfusion Injury
Shared by
Zhong Lin Wang
Beijing Institute of Technology
Histone Deacetylase Inhibition Provides Tissue-Specific Protection after Renal and Liver Ischemia Reperfusion Injury
Article
2018
en
Authors
+5 more
SC
Seth J. Concors
DA
David Aufhauser
DM
Douglas R. Murken
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Histone Deacetylase- 11 Gene Deletion is Protective in Renal Ischemia-Reperfusion Injury
Seth J. Concors
,
David Aufhauser
,
Douglas R. Murken
,
Zhong Lin Wang
,
Guanghui Ge
,
Wayne W. Hancock
,
Matthew H. Levine
Article
2018
Histone Deacetylase-6 Inhibition is Protective in Liver Ischemia-Reperfusion Injury and Acetaminophen Toxicity in a Murine Model
Seth J. Concors
,
Douglas R. Murken
,
David Aufhauser
,
Zhong Lin Wang
,
Guanghui Ge
,
Wayne W. Hancock
,
Matthew H. Levine
Article
2025
HDAC-6 Inhibition Provides Protection Against Acetaminophen-Induced Liver Injury
Lanette M. Christensen
,
C. O'Brien
,
Paul T. Hernandez
,
Seth J. Concors
,
G.-G. Ge
,
Zhong Lin Wang
,
Wayne W. Hancock
,
Matthew H. Levine
Article
2008
Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury
Peter Hill
,
Deepa Shukla
,
Maxine Tran
,
Julián Aragonés
,
H. Terence Cook
,
Peter Carmeliet
,
Patrick H. Maxwell
Article
2025
Alamandine: Protective Effects Against Renal Ischemia‐Reperfusion Injury‐Induced Renal and Liver Damage in Diabetic Rats
Ayşe Nuransoy Cengi̇z
,
Onural Özhan
,
Lokman Hekim Tanrıverdi
,
Feyzi Dogru
,
Azibe Yıldız
,
Alaadin Polat
,
Nigar Vardı
,
Hakan Parlakpınar
Discussion(0)
No comments yet. Be the first to comment.